OFS Capital Corporation (the "Company" or "OFS Capital") (Nasdaq: OFS) announced today that it has commenced an underwritten ...

Protests and passionate debate have long been hallmarks of college life. But university campuses across England have recently ...

Anthem Biosciences IPO oversubscribed 63.86 times, attracting strong QIB support, raising ₹1,016 crore from anchor investors.

Healthcare Design recaps the 2025 HCD Forum event for healthcare design professionals, held at Hotel Polaris in Colorado ...

Since this IPO was fully an OFS, the contract research, development and manufacturing company will not receive any funds, ...

The company filed its Draft Red Herring Prospectus (DRHP) in February and got the SEBI nod on July 8, according to an update ...

According to market observers, unlisted shares of Anthem Biosciences Ltd are currently trading at Rs 733 against its upper ...

Anthem Biosciences' IPO ended on 16 July, with the issue booked over 60 times. Strong demand from qualified institutional ...

This IPO is entirely an offer for sale (OFS) of 5.96 crore equity shares by existing shareholders. The company itself will not receive any money from this offer. The price band has been set at Rs 570 ...

Anthem Biosciences' Rs 3,395 crore IPO was subscribed 63.86 times, exceeding expectations. QIBs showed strong interest, while ...

Anthem Biosciences Ltd's IPO was subscribed 63.86 times by closing day, driven by institutional buyers. The Rs 3,395-crore ...

The Bengaluru-headquartered co-working firm, which submitted its Draft Red Herring Prospectus (DRHP) earlier in February, was ...